Prenatal Detection of Fetal Urological Anomalies: What Ultrasound Can — and Cannot — Tell Us
Introduction
The widespread adoption of prenatal ultrasound over the past four decades has transformed the landscape of pediatric urology in ways that would have been unimaginable to previous generations of surgeons. Conditions that once presented only after months or years of silent kidney damage — hydronephrosis, posterior urethral valves, ureteropelvic junction obstruction — are now frequently identified before birth, sometimes as early as the first trimester.
For the obstetrician, perinatologist, and pediatric urologist, this early detection creates both opportunity and complexity. An opportunity because some conditions can be monitored, timed for delivery, or even treated in utero. Complexity because many prenatally detected anomalies resolve spontaneously, and distinguishing those that will cause long-term harm from those that will not requires skilled interpretation, appropriate follow-up, and avoidance of unnecessary intervention.
This article explains the spectrum of fetal urological anomalies detectable by prenatal ultrasound, how they are diagnosed and graded, and what management pathways the evidence supports.
The Prenatal Ultrasound Revolution in Fetal Urology
How Screening Changed Everything
Before routine prenatal ultrasound, the vast majority of congenital urological anomalies were diagnosed only after symptoms appeared — urinary tract infections, abdominal masses, failure to thrive, or renal failure in infancy or childhood. By that point, significant and often irreversible renal damage had frequently already occurred.
Urinary tract dilation is sonographically identified in 1–2% of fetuses and reflects a spectrum of possible uropathies. This means that in any population with routine prenatal screening, a substantial number of pregnancies will carry a fetus with detectable urinary tract findings — making standardized approaches to evaluation, classification, and follow-up essential.
The clinical benefits of prenatal detection include:
- Early postnatal evaluation before symptomatic UTI or renal damage occurs
- Antibiotic prophylaxis in neonates at risk for obstructive uropathy and vesicoureteral reflux
- Counseling of families about anticipated postnatal management
- Delivery planning — timing and location of birth for severe anomalies requiring immediate neonatal intervention
- Fetal intervention in selected severe cases of lower urinary tract obstruction
The Classification Challenge
There is significant variability in the clinical management of individuals with prenatal urinary tract dilation that stems from a paucity of evidence-based information correlating the severity of prenatal dilation to postnatal urological pathologies. The lack of correlation between prenatal and postnatal ultrasound findings and final urologic diagnosis has been problematic, in large measure because of a lack of consensus and uniformity in defining and classifying urinary tract dilation.
This recognition — that inconsistent terminology and grading systems impede communication and management — led to the development of the Urinary Tract Dilation (UTD) Classification System in 2014, a multisociety consensus effort involving eight major societies to standardize prenatal and postnatal urinary tract dilation assessment.
The Spectrum of Prenatally Detected Urological Anomalies
Hydronephrosis: The Most Common Finding
Hydronephrosis — dilation of the renal pelvis and collecting system — is the most frequently detected fetal urinary tract anomaly, present in approximately 1–2% of all pregnancies. The causes span a wide spectrum:
| Cause | Approximate Frequency in Prenatal Hydronephrosis | Natural History |
| Transient/physiological | ~40–50% | Resolves spontaneously without treatment |
| Ureteropelvic junction (UPJ) obstruction | ~10–30% | Variable; 50–70% resolve; remainder require pyeloplasty |
| Vesicoureteral reflux (VUR) | ~10–15% | Grade-dependent; most low grades resolve |
| Ureterovesical junction (UVJ) obstruction / megaureter | ~5–10% | Many resolve; high grades may require surgery |
| Multicystic dysplastic kidney (MCDK) | ~5% | Involutes; contralateral kidney must be monitored |
| Duplex collecting system | ~5% | Variable; ureteroceles may cause obstruction |
| Posterior urethral valves (PUV) | ~1–2% of prenatal cases | Serious; requires early postnatal intervention |
| Other (prune belly, cloaca, etc.) | < 5% | Variable and complex |
The Society for Fetal Urology (SFU) Grading System
The SFU grading system, developed in the early 1990s, remains widely used for postnatal hydronephrosis assessment:
The Society for Fetal Urology was founded in 1988 to study the postnatal evolution of prenatally detected anomalies of the urinary tract by following those neonates whose prenatal studies have brought them to medical attention while asymptomatic. A system to grade upper tract dilatation or hydronephrosis imaged by ultrasound was developed. The appearance of the calices, renal pelvis, and renal parenchyma are key in determining the grade.
- Grade 0: No dilation
- Grade 1: Only renal pelvis visible; no calyceal dilation
- Grade 2: Pelvis and major calyces visible
- Grade 3: Pelvis, major and minor calyces dilated; normal parenchyma
- Grade 4: As Grade 3 with parenchymal thinning
Higher grades correlate with greater likelihood of significant underlying pathology requiring intervention.
Posterior Urethral Valves: The Most Serious Lower Tract Obstruction
What PUV Is
Posterior urethral valves (PUV) represent the most common and most serious congenital obstructive uropathy in male fetuses. Abnormal tissue leaflets form within the posterior urethra, creating partial or complete bladder outlet obstruction. The consequences cascade proximally:
- Bladder hypertrophy and dysfunction
- Bilateral ureteral dilation (hydroureteronephrosis)
- Progressive renal dysplasia from back-pressure
- In severe cases: oligohydramnios from reduced fetal urine output → pulmonary hypoplasia
The prenatal ultrasound findings in PUV include:
- “Keyhole sign” — the characteristic appearance of a dilated posterior urethra communicating with an enlarged, thick-walled bladder (highly specific for PUV or urethral atresia)
- Bilateral hydroureteronephrosis
- Oligohydramnios or anhydramnios in severe cases
- Echogenic or cystic kidneys indicating dysplasia (poor prognostic sign)
Prognosis and Management
The severity of PUV is highly variable. Prognostic indicators identifiable prenatally include:
- Amniotic fluid volume: oligohydramnios indicates severely compromised renal function; portends poor pulmonary and renal outcomes
- Renal cortical echogenicity: bright, echogenic cortex suggests dysplasia
- Bilateral vs. unilateral hydroureteronephrosis: bilateral worst prognosis
- Gestational age at diagnosis: earlier presentation generally indicates more severe disease
Postnatally, PUV is treated by endoscopic valve ablation — cystoscopic destruction of the valve leaflets — as soon as the neonate is stable. Despite successful ablation, up to 25–30% of boys with PUV progress to chronic kidney disease or end-stage renal failure by early adulthood, making long-term nephrology follow-up essential.
Congenital Megalourethra: A Rare but Diagnosable Anomaly
Definition and Pathophysiology
Congenital megalourethra is abnormal dilation of the penile urethra due to aplasia of erectile tissue, leading to lower urinary tract obstruction. This condition should be considered when a fetal penis with typical dilation is seen on prenatal scan.
Unlike PUV, which obstructs at the bladder outlet, congenital megalourethra results from deficient development of the corpora spongiosum (scaphoid type) or both corpora cavernosa and spongiosum (fusiform type — most severe, associated with prune belly syndrome).
Prenatal Diagnosis
The prenatal sonographic diagnosis involves careful evaluation of the fetal genitalia — a dilated, fluid-filled structure along the penis represents the obstructed penile urethra. Associated findings include bladder distension, hydroureteronephrosis, oligohydramnios, and in severe cases, renal dysplasia.
This is precisely the type of prenatal case series that Prof. Araujo Júnior and UNIFESP colleagues have published — documenting the prenatal sonographic features, clinical course, and outcomes of rare fetal urological anomalies detected in tertiary-level Brazilian prenatal diagnosis centers.
Fetal Intervention for Lower Urinary Tract Obstruction
When Is Prenatal Treatment Considered?
For severe lower urinary tract obstruction (LUTO) — whether from PUV, urethral atresia, or other causes — where oligohydramnios threatens pulmonary development, fetal intervention may be considered:
Some prenatal fetal interventions including serial amnioinfusion, percutaneous shunting, and fetal cystoscopy have been attempted and offer variable results to improve the prognosis and mostly to obtain a pulmonary survivor. These techniques should be adapted case to case, depending on particularities and require a multidisciplinary trained team. Prenatal diagnosis of these urological conditions at an early stage and their categorization are essential to provide accurate parental counseling and fetal therapy.
Vesicoamniotic shunting — placing a drainage catheter percutaneously from the fetal bladder to the amniotic cavity — is the most commonly performed intervention, aimed at:
- Restoring amniotic fluid volume and preventing pulmonary hypoplasia
- Decompressing the urinary tract and potentially preserving residual renal function
The evidence for fetal intervention remains mixed: it improves perinatal survival in severe LUTO by reducing pulmonary hypoplasia, but does not significantly alter long-term renal outcomes, which are largely determined by the degree of pre-existing renal dysplasia at the time of intervention.
Postnatal Follow-Up: From Prenatal Detection to Pediatric Management
The Importance of the Prenatal-Postnatal Continuum
Prenatal detection of a urological anomaly is not an endpoint — it is the beginning of a management pathway that must be carefully structured:
Key postnatal evaluation steps for prenatally detected uropathy:
- Neonatal renal ultrasound — confirm and characterize the anomaly postnatally; obtain baseline measurements
- Voiding cystourethrogram (VCUG) — evaluate for vesicoureteral reflux and posterior urethral valves in appropriate cases
- Diuretic renogram (MAG3 or DTPA) — assess differential renal function and obstruction severity
- Antibiotic prophylaxis — for neonates with significant hydronephrosis at risk of febrile UTI, pending full evaluation
- Nephrology consultation — for bilateral disease or impaired renal function
- Pediatric urology follow-up — to guide surveillance or intervention decisions
Clinicians must follow patients with prenatally detected hydronephrosis to determine which will resolve spontaneously and which will require surgical correction. The kidneys are classified as having poor, moderate or good function based on diuretic renography, and management decisions are guided by functional assessment rather than anatomical dilation alone.
Conclusion
Prenatal ultrasound has fundamentally changed the natural history of congenital urological anomalies — replacing emergency neonatal presentations of renal failure and sepsis with planned, structured postnatal evaluation and management. For the vast majority of prenatally detected anomalies, the prognosis is excellent: most cases of hydronephrosis are either transient or manageable, and modern surgical techniques for PUV, UPJ obstruction, and vesicoureteral reflux achieve excellent outcomes when applied appropriately.
The work of researchers like Prof. Edward Araujo Júnior at UNIFESP — documenting the prenatal sonographic features of rare fetal urological anomalies in Brazilian tertiary centers — contributes essential evidence to this global effort, building the evidence base for prenatal diagnosis in populations and healthcare contexts beyond specialized Western institutions.
Your next steps if a fetal urological anomaly has been detected:
- Request referral to a fetal medicine specialist or maternal-fetal medicine unit with expertise in prenatal urological anomalies — interpretation requires specialized experience
- Ask whether your anomaly requires additional prenatal imaging (including fetal MRI) or simply postnatal follow-up
- Arrange a prenatal consultation with a pediatric urologist and pediatric nephrologist to plan postnatal management before delivery
- Understand that the majority of prenatally detected hydronephrosis cases resolve spontaneously — avoid anxiety until full postnatal assessment is complete
- For severe cases with oligohydramnios, discuss delivery at a tertiary neonatal center prepared for immediate postnatal urological intervention
- Ensure all prenatal ultrasound measurements (renal pelvis AP diameter, amniotic fluid index, renal cortical appearance) are documented and shared with your postnatal care team